Innovent Biologics (1801.HK)_ Tyvyt-led 3Q beat with eyes on next wave of approvals
-·2024-11-03 17:16
30 October 2024 | 11:47PM HKT 2131d4eaf4cb4d50b1d51c8af07b64b4 Innovent Biologics (1801.HK): Tyvyt-led 3Q beat with eyes on next wave of approvals 3Q sales beat with strong momentum maintained: Innovent reported 3Q24 product revenue to exceed Rmb2.3bn (vs. GSe of c.Rmb2bn, +40% y/y, c.15% q/q), maintaining its strong sales performance in the past few quarters (average teens growth q/q since 1Q23) amid the lingering industry-wide anti-corruption disruptions. With accelerated qoq growth, Tyvyt became the majo ...